Frédérique Menzaghi
2021
Compensation breakdown
| Bonus | $93,000 |
|---|---|
| Non-Equity Incentive Plan | $257,709 |
| Option Awards | $423,776 |
| Salary | $465,000 |
| Stock Awards | $486,397 |
| Other | $11,229 |
| Total | $1,737,111 |
Menzaghi received $486.4K in stock awards, accounting for 28% of the total pay in 2021.
Menzaghi also received $93K in bonus, $257.7K in non-equity incentive plan, $423.8K in option awards, $465K in salary and $11.2K in other compensation.
Rankings
In 2021, Frédérique Menzaghi's compensation ranked 6,624th out of 12,415 executives tracked by ExecPay. In other words, Menzaghi earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,624 out of 12,415 | 47th |
Division Manufacturing | 2,862 out of 5,505 | 48th |
Major group Chemicals And Allied Products | 1,259 out of 2,375 | 47th |
Industry group Drugs | 1,123 out of 2,096 | 46th |
Industry Pharmaceutical Preparations | 815 out of 1,546 | 47th |
Pay ratio
| Frédérique Menzaghi's Pay | $1,737,111 |
|---|---|
| Median Employee's Pay | $192,240 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Frédérique Menzaghi was $1,737,111.
The annual total compensation of the median employee at Cara Therapeutics was $192,240.
The ratio of Frédérique Menzaghi's pay to the pay of median employee was therefore 9 to one.
Menzaghi's colleagues
We found five more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2021.
2021
Derek Chalmers
Cara Therapeutics
Chief Executive Officer
2021
Christopher Posner
Cara Therapeutics
Chief Executive Officer
2021
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
2021
Scott Terrillion
Cara Therapeutics
General Counsel
2021
Thomas Reilly
Cara Therapeutics
Chief Financial Officer
News
April 22, 2022
April 23, 2021
April 22, 2020
April 24, 2019